The Administrative Minister of the Presidency, Andrés Bautista, assured this Friday that the recent resurgence of African ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

Uganda's Ministry of Health on Friday confirmed an outbreak of the Crimean-Congo hemorrhagic fever (CCHF) in the western district of Kyegegwa. The laboratory results from samples taken from a ...

NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

Known as severe fever with thrombocytopenia syndrome, or SFTS, the highly fatal viral hemorrhagic fever spreads to humans through ixodid ticks, which are typically found in mountains, forests and ...

KAMPALA, March 14 (Xinhua) -- Uganda's Ministry of Health on Friday confirmed an outbreak of the Crimean-Congo hemorrhagic fever (CCHF) in the western district of Kyegegwa. The laboratory results ...

Lassa fever vaccine is one step closer to approval. Lassa virus infections, primarily spread by rodents, can cause a fatal ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed the death of a 31-year-old physician who recently ...

The Nigeria Centre for Disease Control and Prevention (NCDC) has reported a decline in new confirmed Lassa fever cases across ...